MedPath

Abciximab

Generic Name
Abciximab
Drug Type
Biotech
CAS Number
143653-53-6
Unique Ingredient Identifier
X85G7936GV

Overview

Abciximab is a Fab fragment of the chimeric human-murine monoclonal antibody 7E3. Abciximab binds to the glycoprotein (GP) IIb/IIIa receptor of human platelets and inhibits platelet aggregation by preventing the binding of fibrinogen, von Willebrand factor, and other adhesive molecules. It also binds to vitronectin (αvβ3) receptor found on platelets and vessel wall endothelial and smooth muscle cells.

Indication

Abciximab is indicated as an adjunct to percutaneous coronary intervention for the prevention of cardiac ischemic complications in patients undergoing percutaneous coronary intervention and in patients with unstable angina not responding to conventional medical therapy when percutaneous coronary intervention is planned within 24 hours. Abciximab is intended for use with aspirin and heparin and has been studied only in that setting.

Associated Conditions

  • Ischemic cardiovascular events

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2014/07/08
Phase 3
Completed
2014/04/07
Not Applicable
UNKNOWN
2013/08/30
Phase 2
Withdrawn
2011/12/26
Phase 4
UNKNOWN
CLI Foundation
2011/11/21
Phase 4
Completed
2009/09/29
Phase 4
Completed
Catharina Ziekenhuis Eindhoven
2009/09/14
Not Applicable
Completed
2009/06/29
Phase 4
Completed
Università degli Studi di Ferrara
2009/06/25
Not Applicable
UNKNOWN
2009/05/06
Phase 3
Terminated

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath